Skip to main content
Fig. 9 | BMC Pharmacology and Toxicology

Fig. 9

From: Levocetrizine attenuates cyclophosphamide-induced lung injury through inhibition of TNF-α, IL-1β, TGF-β and MMP-9

Fig. 9

Effect of levocetrizine on MMP-9 (IHC). A and B, Control group: showed negative immunostaining. C–H, Cyclophosphamide (CP) group showed: positive brown expression against MMP-9 in leukocytes infiltrating in peribronchial (arrows), perivascular (arrowheads) and in interstitial tissues (dashed arrows) I-L, Levocetrizine group: very mild positive brown expression against MMP-9 that appears in interstitial tissues (dashed arrows). IHC counterstained with Mayer’s hematoxylin. Low magnification X:100 bar 100 (A, C, E, I, J) and high magnification X:400 bar 50 (B, D, F, G, H, K, L)

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us